Sign inJoin waitlistJoin the waitlist

Jason Aldred

Physician · Selkirk Neurology Pllc

Credentials: · · · · · · ·

History

Selkirk Neurology Pllc
Present

Rheumatology
2008–2010
Portland Veterans Affairs Medical Center
2007–2008
Neurology
2003–2007
Univ of Tennessee Coll of Med
1999–2003
University of Tennessee, Knoxville

Research

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Science Translational Medicine · 2022 · 199 citations
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
The Lancet Neurology · 2022 · 182 citations
National randomized controlled trial of virtual house calls for Parkinson disease
Neurology · 2017 · 167 citations

David Standaert
10 papers
Rajesh Pahwa
9 papers
MS
Michael Soileau
6 papers
Robert Hauser
5 papers
Stuart Isaacson
5 papers
AE
Aaron Ellenbogen
4 papers
Cindy Zadikoff
4 papers
Meredith Spindler
4 papers
Mustafa Siddiqui
4 papers
Thomas Davis
4 papers
Zoltan Mari
4 papers
AH
Anhar Hassan
3 papers

Clinical trials

A Study of Buntanetap in Participants With PD
Site PI · Recruiting · Phase 2, Phase 3
Annovis Bio Inc.
2026–2029
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Site PI · Recruiting · Phase 1
Eli Lilly and Company
2025–2028
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Site PI · Recruiting · Phase 2
Neuron23 Inc.
2025–2028
Parkinson's Foundation PD GENEration Genetic Registry
Site PI · Recruiting
Parkinson's Foundation
2020–2027